Loading
MD Anderson's chief scientist, a cell-cycle biologist who ran drug discovery in industry before leading the centre's research.
Giulio Draetta is Chief Scientific Officer of MD Anderson Cancer Center. A cell-cycle biologist specialising in cancer biology, drug discovery and translational research, he discovered key cyclin-dependent kinase regulators early in his career and later led oncology discovery at Pharmacia and Merck. His papers include two 1988 reports, in Nature and Cell, on the human cdc2 protein kinase as a cell-cycle regulated tyrosine kinase substrate and on its activation during mitosis through phosphorylation and subunit rearrangement. As chief scientist he oversees MD Anderson's research programmes, the Institute for Applied Cancer Science and the Therapeutics Discovery division, with interests in CDK4/6 and AI-driven drug and target discovery.
Shares CDK4/6, MD Anderson Cancer Center.
Shares CDK4/6, MD Anderson Cancer Center.